Grifols, S.A. - Company & Market Research Reports

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.